Literature DB >> 16365912

Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution.

Margarida Gairí1, Pilar Saiz, Sergio Madurga, Xavier Roig, Judit Erchegyi, Steven C Koerber, Jean Claude Reubi, Jean E Rivier, Ernest Giralt.   

Abstract

The three-dimensional structure of a potent SSTR3-selective analogue of somatostatin, cyclo(3-14)H-Cys(3)-Phe(6)-Tyr(7)-D-Agl(8)(N(beta) Me, 2-naphthoyl)-Lys(9)-Thr(10)-Phe(11)-Cys(14)-OH (des-AA(1, 2, 4, 5, 12, 13)[Tyr(7), D-Agl(8)(N(beta) Me, 2-naphthoyl)]-SRIF) (peptide 1) has been determined by (1)H NMR in water and molecular dynamics (MD) simulations. The peptide exists in two conformational isomers differing mainly by the cis/trans isomerization of the side chain in residue 8. The structure of 1 is compared with the consensus structural motifs of other somatostatin analogues that bind predominantly to SSTR1, SSTR2/SSTR5 and SSTR4 receptors, and to the 3D structure of a non-selective SRIF analogue, cyclo(3-14)H-Cys(3)-Phe(6)-Tyr(7)-D-2Nal(8)-Lys(9)-Thr(10)-Phe(11)-Cys(14)-OH (des-AA(1, 2, 4, 5, 12, 13)[Tyr(7), D-2Nal(8)]-SRIF) (peptide 2). The structural determinant factors that could explain selectivity of peptide 1 for SSTR3 receptors are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365912     DOI: 10.1002/psc.743

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  5 in total

1.  Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.

Authors:  Judit Erchegyi; Renzo Cescato; Christy Rani R Grace; Beatrice Waser; Véronique Piccand; Daniel Hoyer; Roland Riek; Jean E Rivier; Jean Claude Reubi
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

2.  Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.

Authors:  Judit Erchegyi; Christy Rani R Grace; Manoj Samant; Renzo Cescato; Veronique Piccand; Roland Riek; Jean Claude Reubi; Jean E Rivier
Journal:  J Med Chem       Date:  2008-04-12       Impact factor: 7.446

3.  Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.

Authors:  Christy Rani R Grace; Judit Erchegyi; Jean Claude Reubi; Jean E Rivier; Roland Riek
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

4.  Peptide aromatic interactions modulated by fluorinated residues: Synthesis, structure and biological activity of Somatostatin analogs containing 3-(3',5'difluorophenyl)-alanine.

Authors:  Pablo Martín-Gago; Álvaro Rol; Toni Todorovski; Eric Aragón; Pau Martin-Malpartida; Xavier Verdaguer; Mariona Vallès Miret; Jimena Fernández-Carneado; Berta Ponsati; Maria J Macias; Antoni Riera
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

5.  Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease.

Authors:  Álvaro Rol; Toni Todorovski; Pau Martin-Malpartida; Anna Escolà; Elena Gonzalez-Rey; Eric Aragón; Xavier Verdaguer; Mariona Vallès-Miret; Josep Farrera-Sinfreu; Eduard Puig; Jimena Fernández-Carneado; Berta Ponsati; Mario Delgado; Antoni Riera; Maria J Macias
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.